The synthetic “tetracycline-on” switch, was used to regulate expression of double shRNAs targeting CCAT2 in response to different contentrations of doxycycline and to suppress progression of bladder cancer cells. The gene discussed is CCAT2; the disease is urinary bladder carcinoma.